EYE - National Vision Holdings, Inc. Average Forecast Price

Corporate company logo of National Vision Holdings, Inc. (EYE)

The financial price action for National Vision Holdings (EYE) illustrates the dynamics of a company developing a closed-loop cycle of optical sales and diagnostics, where the indicator stands at 27.02. The business retains budget-conscious consumers through a comprehensive service suite, although a rift with partners has weakened the system. Stability is ensured by ownership of brands across various price points and a relationship with Walmart. Growth is based on affordable pricing and the scaling of its own proprietary frame lines.

EYE America's Best Contacts & Eyeglasses Consensus Target (07/04/2022 - 11/14/2026)

Analytical breakdowns for National Vision Corp (EYE)

- current quotes and average value forecast:
General company analysis:EYE nationalvision.com
Finished products of National Vision

Investors must find a balance between operating expenses and return on equity. National Vision Holdings (EYE) is developing a business model with low pricing power, relying on high volume and in-house production. The current consensus valuation reflects the arithmetic mean of target prices from leading analysts. This indicator's trend captures phases of market consolidation and fundamental asset revaluation. The stability of the line confirms the resilience of the budget retail strategy.

Who National Vision Holdings competes with

HCA - Average Forecast Price|Tenet Healthcare Corporation - Consensus Target|Fresenius Medical Care AG (FMS) - Average Forecast Price|Solventum Inc. - Analyst Consensus Forecast|Average Forecast Price Encompass|UHS (uhsinc.com) - Consensus Target|DVA: Analyst Forecast Prices|Price Target Chart RadNet|OPCH: Fair Value Consensus|Analyst Consensus Forecast SGRY|PINC - Average Forecast Price|Analyst Consensus Forecast PGNY (Progyny, Inc.)|Analyst Consensus Forecast ardenthealth.com ARDT|SEM: Consensus Target|Astrana Health Inc - Analyst Forecast Prices|Pediatrix Medical Group (MD) - Price Target Chart|Consensus Target U.S. Physical Therapy, Inc.|PNTG (The Pennant Group, Inc.) - Analyst Consensus Forecast|Average Forecast Price organogenesis.com ORGO|Price Target Chart Nutex Health (NUTX)|Auna S.A. - Broker Consensus Forecast|sbc-holdings.com - Consensus Target|Analyst Forecast Prices EOLS (Evolus Corp)|CYH - Price Target Chart|SKIN (The Beauty Health) - Broker Consensus Forecast|MDWD: Analyst Consensus Forecast|Biote (BTMD) - Analyst Consensus Forecast|Consensus Target JYNT|DCGO (DocGo, Inc) - Analyst Forecast Prices|Analyst Consensus Forecast PIII|Analyst Median Target Gain Therapeutics Inc.|Price Target Chart EUDA Health EUDA|Basel Medical (BMGL) - Average Forecast Price|CLGN - Price Target Chart|CUPR (Cuprina Holdings Limited) - Broker Consensus Forecast|CCM: Analyst Consensus Forecast|ashs.com (AMS) - Analyst Consensus Forecast|Price Target Chart MEDIROM Healthcare Group|Price Target Chart ALBT|Consensus Target DHAI (DIH Holding US Inc.)|XAGE (Carmell Corp) - Fair Value Consensus|NewGenIvf Group Limited - Consensus Target|ATI Physical Therapy Inc. - Price Target Chart|CareMax - Analyst Consensus Forecast|Analyst Median Target Kindly MD Inc KDLY|LogistiCare (MODV) - Price Target Chart|NVOS - Analyst Median Target|SSY (SunLink Health Systems Inc.) - Analyst Consensus Forecast|imacholdings.comm (BACK) - Analyst Median Target